Investors Research Corp’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$182K Sell
2,358
-57
-2% -$4.16K 0.03% 279
2026
Q1
$158K Sell
2,415
-227
-9% -$16.9K 0.03% 290
2025
Q4
$209K Hold
2,642
0.04% 287
2025
Q3
$193K Hold
2,642
0.04% 304
2025
Q2
$200K Hold
2,642
0.04% 302
2025
Q1
$201K Hold
2,642
0.04% 292
2024
Q4
$175K Sell
2,642
-25
-0.9% -$1.75K 0.04% 314
2024
Q3
$186K Hold
2,667
0.04% 317
2024
Q2
$141K Buy
+2,667
New +$162K 0.03% 357

Other funds holding SOLV

Investors Research Corp's SOLV Position: Q2 2026 in Review

Investors Research Corp reduced its Solventum (SOLV) stake by 2.4% in Q2 2026, selling an estimated $4.16K and leaving 2,358 shares worth $182K. The position accounts for 0.03% of the portfolio, ranked #279.

Investors Research Corp first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $209K in Q4 2025. 875 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Investors Research Corp held 2,358 shares of Solventum worth $182K as of Q2 2026.
  • Investors Research Corp sold 57 Solventum shares in Q2 2026, an estimated $4.16K.
  • Solventum made up 0.03% of Investors Research Corp's portfolio in Q2 2026, its #279 holding.
  • Investors Research Corp first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Investors Research Corp's Solventum position peaked at $209K in Q4 2025.
  • 875 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Investors Research Corp's 13F filing for Q2 2026, filed 10 Jul 2026.